Syncona is a leading FTSE250 company focused on founding, building and funding global leaders in life science
Syncona is a leading FTSE250 company focused on founding, building and funding global leaders in life science
We aim to deliver transformational treatments to patients in truly innovative areas of healthcare while generating superior returns for shareholders.
Sign up to get the latest RNS, company news, share price information and results from Syncona.